NFKB1 and ovarian cancer: Similar inhibitory effects by MBZ were observed for the NFKB (Figure 4B-b), MYC/MAX (Figure 4B-c), and E2F/DP1 (Figure 4B-d) reporter activities, suggesting that MBZ may exert profound inhibitory effects on cell proliferation pathways in cisplatin-resistant ovarian cancer cells.